NCT02923154View on ClinicalTrials.gov

Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

April 30, 2019

Conditions
NASH
Interventions
DRUG

MT-3995

DRUG

Placebo

Trial Locations (2)

Unknown

Investigational site, Kanagawa

Investigational site, Osaka

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY